Cesaretti Manuela, Trotta Manuela, Varaldo Emanuela, Ansaldo Gianluca, Leale Irene, Borgonovo Giacomo
Tumori. 2013 May-Jun;99(3):e107-10. doi: 10.1177/030089161309900327.
Metastases to the thyroid gland from renal cancer pose a challenge to physicians, due in part to the rarity of the phenomenon, the prolonged time interval between removal of the primary renal cancer and the appearance of metastases, the difficulty in diagnosis, and the uncertainty regarding long-term prognosis. We report our experience with diagnosis and management of patients affected by thyroid metastases from renal clear cell carcinoma.
We report herein three clinical cases of thyroid metastases from renal clear cell carcinoma. We also present a review of the literature and examine common features of clinical presentation and management recommendations.
Over the past 17 years, 918 patients underewent surgery for thyroid cancer in our institution. Histological examination demonstrated a thyroid secondary malignancy from kidney cancer in 3 cases. Two patients underwent total thyroidectomy, whereas in the third patient a palliative right lobectomy with homolateral latero-cervical lymphoadenectomy was performed. At a 5-year follow-up, only one patient survived and was disease-free.
Thyroid metastases from renal clear cell carcinoma are a rare occurrence but should be taken into consideration in the differential diagnosis of a thyroid nodule. Preoperative diagnosis is often difficult. Nevertheless, an extensive diagnostic workup is recommended because the subsequent therapy must be tailored on the basis of the local extension of metastases. Surgical treatment of solitary thyroid metastases is recommended. However, patients with disseminated disease have a poor prognosis, and palliative care is the indicated recommendation. In these patients and in surgically untreatable patients, prolonged survival may be achieved by adjuvant medical therapy.
肾癌转移至甲状腺给医生带来了挑战,部分原因在于这种现象罕见、原发性肾癌切除与转移灶出现之间的时间间隔较长、诊断困难以及长期预后的不确定性。我们报告了对肾透明细胞癌甲状腺转移患者的诊断和管理经验。
我们在此报告3例肾透明细胞癌甲状腺转移的临床病例。我们还对文献进行了综述,并探讨了临床表现的共同特征和管理建议。
在过去17年中,我们机构有918例患者接受了甲状腺癌手术。组织学检查显示3例为肾癌转移至甲状腺的继发性恶性肿瘤。2例患者接受了全甲状腺切除术,而第3例患者进行了姑息性右叶切除术并同期进行了同侧颈侧区淋巴结清扫术。在5年的随访中,只有1例患者存活且无疾病。
肾透明细胞癌甲状腺转移罕见,但在甲状腺结节的鉴别诊断中应予以考虑。术前诊断通常困难。然而,建议进行广泛的诊断检查,因为后续治疗必须根据转移灶的局部扩展情况进行调整。建议对孤立性甲状腺转移进行手术治疗。然而,播散性疾病患者预后较差,姑息治疗是推荐的建议。在这些患者以及无法进行手术治疗的患者中,辅助药物治疗可能会延长生存期。